JWC_OT-15-001

A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy (STELLAR Study)

The purpose of this study is to compare the efficacy and safety of eflornithine in combination with lomustine, compared to lomustine taken alone, in treating patients whose anaplastic astrocytoma has recurred/progressed after radiation and temozolomide chemotherapy.
Phase III
NCT02796261
Cancer
Brain
Santosh Kesari, M.D.
Orbus Therapeutics, Inc.
Jaya Gill, RN
  • John Wayne Cancer Institute (JWCI)
  • Providence St. Johns Health Center (PSJHC)